Clinic
DR. Said Attoussi INC
DR. Said Attoussi INC was paid $2.12M by Medicaid between Jan 2018 and Dec 2024, across 88 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 31% of everything it billed.
33Billing provider infoDR. SAID ATTOUSSI INC
NASHVILLE, TN 37211
NASHVILLE, TN 37211
33aNPI1215117759assigned 11/13/2007
33bProvider typePrimary Care Clinic/Center
28Total paid$2.12M
24GClaims101,494
24DCodes billed88
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Primary Care Clinic/Center providers in Tennessee
Rank by total paid#11 of 139
Median peer was paid$101K
This provider vs. median21×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 23,355 | $486K | |
| 2019 | 17,842 | $449K | |
| 2020 | 14,256 | $303K | |
| 2021 | 15,181 | $278K | |
| 2022 | 12,831 | $244K | |
| 2023 | 11,676 | $231K | |
| 2024incomplete | 6,353 | $130K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 31% | 11,636 | 9,340 | $656K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 25% | 13,711 | 11,550 | $529K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 6.1% | 1,643 | 1,340 | $130K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 3.9% | 5,422 | 4,298 | $82K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 3.8% | 1,103 | 941 | $80K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 3.3% | 973 | 862 | $70K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 3.1% | 5,484 | 4,748 | $66K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 2.3% | 695 | 600 | $48K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 2.3% | 1,584 | 1,375 | $48K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.9% | 3,803 | 1,728 | $40K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 1.8% | 690 | 620 | $39K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 1.6% | 494 | 451 | $33K |
76 more codes
| 83037 | 1.5% | 3,908 | $31K | |
| 90674 | 1.4% | 1,410 | $29K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | 1.1% | 1,695 | $24K |
| 3008F | <1% | 5,042 | $18K | |
| 81000 | <1% | 6,230 | $17K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 2,010 | $13K |
| 90686 | <1% | 1,882 | $11K | |
| 90715 | <1% | 509 | $9K | |
| 93000 | <1% | 550 | $8K | |
| 92553 | <1% | 425 | $8K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 197 | $8K |
| 81025 | <1% | 1,507 | $7K | |
| 81002 | <1% | 4,511 | $7K | |
| 90732 | <1% | 77 | $7K | |
| 96127 | <1% | 2,166 | $7K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 253 | $6K |
| 90677 | <1% | 32 | $6K | |
| 90716 | <1% | 199 | $6K | |
| 82044 | <1% | 1,203 | $5K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 3,839 | $5K |
| 85018 | <1% | 2,201 | $4K | |
| 90756 | <1% | 218 | $4K | |
| 90734 | <1% | 389 | $4K | |
| 87430 | <1% | 355 | $3K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 213 | $3K |
| 99441 | <1% | 276 | $3K | |
| 1159F | <1% | 1,210 | $3K | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 1,098 | $2K |
| 0011A | <1% | 84 | $2K | |
| 1160F | <1% | 1,138 | $2K | |
| 90651 | <1% | 559 | $2K | |
| 99177 | <1% | 448 | $2K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,951 | $2K |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | <1% | 19 | $2K |
| 3074F | <1% | 731 | $2K | |
| 90656 | <1% | 109 | $2K | |
| 0012A | <1% | 57 | $2K | |
| 3078F | <1% | 538 | $2K | |
| 92551 | <1% | 210 | $2K | |
| 99173 | <1% | 333 | $2K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 494 | $1K |
| 90688 | <1% | 110 | $1K | |
| 92250 | <1% | 31 | $1K | |
| 3079F | <1% | 296 | $1K | |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | <1% | 33 | $1K |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | <1% | 33 | $848.84 |
| 82962 | <1% | 474 | $842.77 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 86 | $837.30 |
| 86769 | <1% | 23 | $631.95 | |
| 3044F | <1% | 760 | $550.00 | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 13 | $496.56 |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 28 | $422.68 |
| 3075F | <1% | 123 | $420.00 | |
| 0004A | <1% | 16 | $416.80 | |
| 96130 | <1% | 29 | $400.00 | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 13 | $365.50 |
| 90707 | <1% | 31 | $355.30 | |
| 1157F | <1% | 35 | $350.00 | |
| 99401 | <1% | 29 | $303.08 | |
| 90713 | <1% | 246 | $290.41 | |
| 96103 | <1% | 47 | $284.26 | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 69 | $263.29 |
| G0136 | Administration of a standardized, evidence-based assessment of physical activity and nutrition, 5-15 minutes, not more often than every 6 months | <1% | 30 | $232.12 |
| 90658 | <1% | 58 | $229.08 | |
| 90661 | <1% | 54 | $210.00 | |
| 3061F | <1% | 60 | $170.00 | |
| 2022F | <1% | 29 | $110.00 | |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 36 | $25.23 |
| J1071 | Injection, testosterone cypionate, 1 mg | <1% | 257 | $9.49 |
| G0008 | Administration of influenza virus vaccine | <1% | 102 | $0.35 |
| 99000 | 0% | 550 | $0.00 | |
| 90619 | 0% | 21 | $0.00 | |
| 90744 | 0% | 17 | $0.00 | |
| 90633 | 0% | 185 | $0.00 | |
| 90714 | 0% | 43 | $0.00 | |
| 81003 | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialATTOUSSI, SAID (PRESIDENT)